For instance, Entinostat (MS-275), a Class I-specific HDAC inhibitor, significantly reduces myocardial infarction size and improves left ventricular function and tissue vitality, thereby protecting cardiac systolic function after ischemia–reperfusion [119,120]. This evidence concerns the gene HDAC9 and myocardial infarction.